Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 25,902 | 31,418 | 29,323 |
| Gross Profit | N/A | N/A | 25,902 | 31,418 | 29,323 |
| Operating Expenses | 14,095 | 11,869 | 69,376 | 83,249 | 63,244 |
| Operating Income | -14,095 | -11,869 | -43,474 | -51,831 | -33,921 |
| Interest Expense | 4,317 | -6,265 | 0 | 0 | 0 |
| Other Income | 978 | 24,295 | 10,197 | 6,093 | -3,145 |
| Pre-tax Income | -17,434 | 18,691 | -33,277 | -45,738 | -37,066 |
| Income Tax | N/A | N/A | N/A | N/A | 164 |
| Net Income Continuous | -17,434 | 18,691 | -33,277 | -45,738 | -37,230 |
| Net Income | $-17,434 | $18,691 | $-33,277 | $-45,738 | $-37,230 |
| EPS Basic Total Ops | -7.83 | 2.19 | -36.00 | -56.80 | -54.40 |
| EPS Basic Continuous Ops | -7.83 | 10.56 | -35.89 | -56.69 | -54.67 |
| EPS Diluted Total Ops | -7.83 | 2.17 | -36.00 | -56.80 | -54.40 |
| EPS Diluted Continuous Ops | -7.83 | 10.42 | -35.89 | -56.69 | -54.67 |
| EPS Diluted Before Non-Recurring Items | -7.83 | -9.60 | -36.00 | -56.80 | -54.40 |
| EBITDA(a) | $-14,095 | $-11,869 | $-40,704 | $-49,372 | $-31,610 |